Background Attention deficit hyperactivity disorder (ADHD) affects approximately 3% of
adults globally. Many pharmacologic treatments options exist, yet the comparative benefits …

Background Attention deficit hyperactivity disorder (ADHD) is one of the most common
neurodevelopmental disorders of children and adolescents, with a significant impact on …

Our review describes potential weight-altering effects of psychotropic medications
(antipsychotics, antidepressants, anti-anxiety medications, mood stabilizers, sedative …

Introduction: Attention-deficit hyperactivity disorder (ADHD) is a common neurobehavioral
disorder of which the main features are inattention, hyperactivity and impulsivity …

A Cochrane systematic review on immediate-release methylphenidate for adults with
attention deficit hyperactivity disorder (ADHD) was withdrawn from the Cochrane Library on …

Background Attention deficit hyperactivity disorder (ADHD) is a psychiatric diagnosis
increasingly used in adults. The recommended first‐line pharmacological treatment is …

Even though several studies have demonstrated the positive effect of mindfulness
meditation on measures of mental and physical well-being, very few studies have been …

Objective: This study tested a novel feed-forward modeling (FFM) system as a
nonpharmacological intervention for the treatment of ADHD children and the training of …

Objective To assess seizure control and tolerability of eslicarbazepine acetate (ESL) as
adjunctive therapy to one baseline antiepileptic drug (AED), in adults with partial‐onset …

Context. Methylphenidate intoxications mostly have a relatively mild course, although
serious complications can occur. Objective. We aimed to characterize methylphenidate …